Quantcast

Micro-cap health products company Guardion Health Sciences revises terms ahead of $9 million IPO


Shutterstock photo

Guardion Health Sciences, which sells medical food and devices for retinal diseases, revised the terms for its upcoming IPO on Wednesday. Deal timing has not been determined.

The San Diego, CA-based company still plans to raise $9 million, but has changed its price to $4 from a range of $3 to $4 and has reduced the number of shares that it is offering to 2.2 million from 2.5 million. With these new terms, Guardion Health Sciences would command a fully diluted market value of $96 million up 14% from its previously proposed market value of $84 million. 

Guardion Health Sciences was founded in 2009 and booked $1 million in revenue for the 12 months ended September 30, 2018. It plans to list on the NYSE under the symbol GHSI. WallachBeth Capital is the sole bookrunner on the deal.

The article Micro-cap health products company Guardion Health Sciences revises terms ahead of $9 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.




This article appears in: News Headlines , IPOs



More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs










Research Brokers before you trade

Want to trade FX?